Latest Insider Transactions at Mirum Pharmaceuticals, Inc. (MIRM)
This section provides a real-time view of insider transactions for Mirum Pharmaceuticals, Inc. (MIRM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mirum Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mirum Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,500
-50.75%
|
$117,500
$47.1 P/Share
|
|
Nov 14
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+33.67%
|
$5,000
$2.94 P/Share
|
|
Nov 08
2024
|
Joanne Quan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
118
+50.0%
|
$2,478
$21.05 P/Share
|
|
Nov 08
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.05%
|
$1,365
$21.05 P/Share
|
|
Nov 08
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
475
+1.41%
|
$9,975
$21.05 P/Share
|
|
Sep 27
2024
|
Michael G Grey |
SELL
Bona fide gift
|
Indirect |
102,788
-35.54%
|
-
|
|
Sep 18
2024
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
115
+0.07%
|
$4,255
$37.4 P/Share
|
|
Sep 11
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,334
+35.85%
|
-
|
|
Sep 06
2024
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
230
+0.14%
|
$9,430
$41.58 P/Share
|
|
Jul 23
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
34,013
+21.15%
|
$68,026
$2.94 P/Share
|
|
Jul 02
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
375
-13.39%
|
$12,750
$34.0 P/Share
|
|
Jul 01
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+27.11%
|
-
|
|
Jun 24
2024
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
30,559
-52.72%
|
$1,039,006
$34.0 P/Share
|
|
Jun 24
2024
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,559
+34.52%
|
$61,118
$2.94 P/Share
|
|
Jun 05
2024
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$125,000
$25.68 P/Share
|
|
Jun 05
2024
|
Saira Ramasastry |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$70,000
$14.12 P/Share
|
|
May 10
2024
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
94
+0.34%
|
$1,974
$21.05 P/Share
|
|
May 10
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
817
+0.87%
|
$17,157
$21.05 P/Share
|
|
May 10
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
470
+3.15%
|
$9,870
$21.05 P/Share
|
|
Mar 27
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+12.5%
|
$48,000
$24.8 P/Share
|
|
Mar 25
2024
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
4,303
-12.92%
|
$107,575
$25.8 P/Share
|
|
Mar 18
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+14.29%
|
$50,000
$25.8 P/Share
|
|
Feb 02
2024
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
847
-0.8%
|
$22,022
$26.19 P/Share
|
|
Feb 02
2024
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,214
-4.06%
|
$31,564
$26.19 P/Share
|
|
Feb 02
2024
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,790
-4.91%
|
$46,540
$26.19 P/Share
|
|
Feb 02
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,013
-5.46%
|
$156,338
$26.19 P/Share
|
|
Feb 02
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
735
-29.47%
|
$19,110
$26.19 P/Share
|
|
Jan 31
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,772
+41.54%
|
-
|
|
Jan 08
2024
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
1,019
-0.96%
|
$28,532
$28.04 P/Share
|
|
Jan 08
2024
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,408
-3.72%
|
$39,424
$28.03 P/Share
|
|
Jan 08
2024
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,408
-4.5%
|
$39,424
$28.03 P/Share
|
|
Jan 08
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
528
-42.24%
|
$14,784
$28.04 P/Share
|
|
Jan 08
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,209
-4.52%
|
$145,852
$28.03 P/Share
|
|
Jan 06
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+50.0%
|
-
|
|
Dec 05
2023
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$80,000
$32.4 P/Share
|
|
Dec 05
2023
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$5,000
$2.94 P/Share
|
|
Nov 10
2023
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
527
+1.66%
|
$11,594
$22.29 P/Share
|
|
Nov 10
2023
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
218
+0.57%
|
$4,796
$22.29 P/Share
|
|
Nov 10
2023
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
434
+0.41%
|
$9,548
$22.29 P/Share
|
|
Nov 09
2023
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,910
+1.77%
|
$81,480
$28.3 P/Share
|
|
Sep 14
2023
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
14,216
-100.0%
|
$454,912
$32.0 P/Share
|
|
Sep 14
2023
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
14,216
+50.0%
|
$28,432
$2.94 P/Share
|
|
Sep 13
2023
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,625
+1.62%
|
$81,375
$31.02 P/Share
|
|
Sep 13
2023
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
392
-100.0%
|
$12,544
$32.0 P/Share
|
|
Sep 13
2023
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
392
+50.0%
|
$784
$2.94 P/Share
|
|
Sep 12
2023
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
3,750
+2.34%
|
$112,500
$30.6 P/Share
|
|
Sep 11
2023
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
4,687
+2.98%
|
$140,610
$30.3 P/Share
|
|
Sep 11
2023
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$290,000
$29.65 P/Share
|
|
Aug 31
2023
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
147,991
+50.0%
|
$3,847,766
$26.25 P/Share
|
|
Aug 25
2023
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
3,459
-100.0%
|
$89,934
$26.23 P/Share
|